Sun S et al. by analyzing PGK1 at protein and mRNA level in breast carcinoma cases have found that high PGK1 expression is associated with worse overall survival and concluded that PGK1 may be considered as a predictive biomarker of chemoresistance to paclitaxel treatment in breast cancer (92). Here, PGK1 is linked to breast cancer.